Pharmaceutical usage is growing in emerging markets, primarily driven by three trends: volume growth of inexpensive generic medicines used to treat chronic diseases such as diabetes, cancer, chronic obstructive pulmonary disease, heart disease and even HIV in a growing and aging population; increased ability to pay for needed medicines through government programs, such as universal health coverage; and rise of urban middle classes able to increase...
Voir la suite
INFORMATION
-
2017/01/01
-
Document de travail
-
113256
-
1
-
1
-
2017/03/09
-
Disclosed
-
Private sector pharmaceutical distribution and retailing in emerging markets : making the case for investment
-
local ngo
TÉLÉCHARGER
RAPPORT COMPLET
Version officielle du document (peut inclure des signatures etc…)
-
Total Downloads** : 3223
*La version texte est une version à reconnaissance optique de caractères non-corrigée. Cette version est fournie uniquement pour accommoder les utilisateurs disposant de connections lentes.